Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session

High Content Phenotypic Characterization for Prostate Cancer Drug Discovery

Tue, Jul 6, 2021 · 6:00 PM · Amsterdam
About This Webinar

Jonathan Sexton from the University of Michigan will show how he has used advanced phenotypic methods that incorporate automated microscopy, high content image analysis, and artificial intelligence for the development of a novel drug discovery platform for drug-resistant prostate cancer.

David Egan from Core Life Analytics will demonstrate how StratoMiner gives biologists access to the full power of phenotypic methods in their efforts to craft knowledge from data.

All presentations will be live and there will be a live Q&A session after the presentations.

Agenda
  • Introduction: Victor Wong, Core Life Analytics
  • Exploratory data analysis to define clinically-relevant drug resistance phenotypic target in neuroendocrine prostate cancer: jonathan Sexton, U. of Michigan
  • Phenotypic Data Analysis for Biologists with StratoMineR: David Egan, Core Life Analytics
Who can view: Everyone
Webinar Price: Free
Featured Presenters
Webinar hosting presenter
Assistant Professor of Internal Medicine, University of Michigan
The Sexton lab focuses primarily on phenotypic-based drug discovery and development for the interrelated set of disorders involving diabetes, obesity, metabolic syndrome, and associated complications. They use functional outcomes of tissues and cells to guide drug discovery around metabolic endpoints. The current strategy for drug development uses a combination of phenotypic and molecular target-driven approaches with core competencies in pancreatic islet technologies, fatty liver disease, and metabolic regulation in muscle tissue coupled with in vivo models of diabetes and obesity. The main technology focus is high content screening - an automated epifluorescence microscopy approach to biological imaging coupled with image analysis to yield quantitative and clinically relevant endpoints in cellular models of disease.
Webinar hosting presenter David Egan
CEO, Core Life Analytics
At Core Life Analytics we have a passion for the democratization of data science. Our StratoMineR platform gives biologists the ability to independently mine their or datasets, allowing them to leverage the full power of phenotypic screening & profiling methods.
Webinar hosting presenter
Application Scientist, Core Life Analytics
Victor Wong has a strong background in using cell and molecular biology and physiological tools for various diseases areas, ranging from metabolic disorders, audiology and neuroscience. He completed one of his postdoctoral fellowships Weill Cornell Medicine using high-throughput (HTS) and high content screening (HCS) approaches. It was at this point where Victor realized a growing problem: HCS approaches precipitated a growing problem where the capacity for data analysis was overwhelmed by the speed at which the data was being generated. Victor joined Core Life Analytics looking to empower biologists to quickly find useful biological insights in large complex data to accelerate their discovery process.
Hosted By
Attended (40) View all
  • 1622816710-5cd336cc7e666414
  • V
  • 1622195814-85b96046fd6dbb6a
  • 1622722514-2cde1732c9da0a3e
  • R
  • V
  • B
  • P
  • R
  • D
  • M
  • G
  • W
  • S
  • S
  • M
  • J